SARIGIANNIS, Dimosthenis A., Spyros KARAKITSIOS, Elena DOMINGUEZ ROMERO, Krystalia PAPADAKI, Celine BROCHOT, Vikas KUMAR, Marta SCHUMACHER, Moustapha SY, Hans MIELKE, Mathias GREINER, Marcel MENGELERS a Martin SCHERINGER. Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative. Environmental Research. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2019, roč. 172, May, s. 216-230. ISSN 0013-9351. Dostupné z: https://dx.doi.org/10.1016/j.envres.2019.01.045.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative
Autoři SARIGIANNIS, Dimosthenis A. (300 Řecko), Spyros KARAKITSIOS (300 Řecko), Elena DOMINGUEZ ROMERO (724 Španělsko, domácí), Krystalia PAPADAKI (300 Řecko), Celine BROCHOT (250 Francie), Vikas KUMAR (724 Španělsko), Marta SCHUMACHER (724 Španělsko), Moustapha SY (276 Německo), Hans MIELKE (276 Německo), Mathias GREINER (276 Německo), Marcel MENGELERS (528 Nizozemské království) a Martin SCHERINGER (756 Švýcarsko, garant, domácí).
Vydání Environmental Research, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2019, 0013-9351.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW Full Text
Impakt faktor Impact factor: 5.715
Kód RIV RIV/00216224:14310/19:00110376
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1016/j.envres.2019.01.045
UT WoS 000468377500023
Klíčová slova anglicky PBTK modelling; Internal dose; Human biomonitoring; HBM4EU
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 24. 3. 2020 09:59.
Anotace
Given the opportunities provided by internal dosimetry modelling in the interpretation of human biomonitoring (HBM) data, the assessment of the links between exposure to chemicals and observed HBM data can be effectively supported by PBTK modelling. This paper gives a comprehensive review of available human PBTK models for compounds selected as a priority by the European Human Biomonitoring Initiative (HBM4EU). We highlight their advantages and deficiencies and suggest steps for advanced internal dose modelling. The review of the available PBTK models highlighted the conceptual differences between older models compared to the ones developed recently, reflecting commensurate differences in research questions. Due to the lack of coordinated strategies for deriving useful biomonitoring data for toxicokinetic properties, significant problems in model parameterisation still remain; these are further increased by the lack of human toxicokinetic data due to ethics issues. Finally, questions arise as well as to the extent they are really representative of interindividual variability. QSARs for toxicokinetic properties is a complementary approach for PBTK model parameterisation, especially for data poor chemicals. This approach could be expanded to model chemico-biological interactions such as intestinal absorption and renal clearance; this could serve the development of more complex generic PBTK models that could be applied to newly derived chemicals. Another gap identified is the framework for mixture interaction terms among compounds that could eventually interact in metabolism. From the review it was concluded that efforts should be shifted toward the development of generic multi-compartmental and multi-route models, supported by targeted biomonitoring coupled with parameterisation by both QSAR approach and experimental (in-vivo and in-vitro) data for newly developed and data poor compounds.
Návaznosti
733032, interní kód MUNázev: European Human Biomonitoring Initiative (Akronym: HBM4EU)
Investor: Evropská unie, European Human Biomonitoring Initiative, Health, demographic change and wellbeing (Societal Challenges)
VytisknoutZobrazeno: 7. 5. 2024 19:30